NCT03407573

Brief Summary

The investigator wishes to see if it is possible to undertake a study comparing blood transfusion at two different levels of anaemia to see which is best for patients. All patients that present to hospital with a broken hip will be able to take part in the study. If they become anaemic during their treatment they will be allocated to either be transfused when their blood count is less that 9 or less than 7. In all patients, we will measure heart damage with a blood test that is very sensitive. The investigator will also collect data on the incidence of heart attacks and other complications.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 22, 2017

Completed
7 months until next milestone

Study Start

First participant enrolled

October 1, 2017

Completed
4 months until next milestone

First Posted

Study publicly available on registry

January 23, 2018

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2019

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2019

Completed
Last Updated

March 11, 2020

Status Verified

March 1, 2018

Enrollment Period

1.4 years

First QC Date

February 22, 2017

Last Update Submit

March 9, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Myocardial Injury

    Myocardial injury defined as a high sensitivity cardiac Troponin 1 (Troponin) concentration above the upper reference limit \[URL\] OF 16 ng L and 34 ng L in women and men respectively at any time during the study period.

    Upto 60 days

Secondary Outcomes (6)

  • Myocardial Infarction

    within 30 days of surgery

  • Mortality

    upto 60 days following surgery

  • Diagnosis of Major Adverse Cardiac Events

    within 30 days or before hospital discharge

  • Acute Kidney Injury

    within 30 days of surgery or before discharge from hospital whichever occurs first.

  • Infections

    within 30 days of surgery or before hospital discharge, whichever is first.

  • +1 more secondary outcomes

Other Outcomes (11)

  • Troponin

    within 7 days of surgery (ngL )

  • Troponin -Time

    within 7 days of surgery

  • Red cells transfused

    within7 days of surgery and within 30 days of surgery or before hospital discharge, whichever occurs first.

  • +8 more other outcomes

Study Arms (2)

Restrictive

ACTIVE COMPARATOR

Restrictive transfused when Hb at or below 70

Biological: Administration of Red Cell

Liberal

ACTIVE COMPARATOR

Will receive blood transfusion when Hb drops below or equal to 90

Biological: Administration of Red Cell

Interventions

Transfusion of red cells dependent on haemoglobin level. Either transfused at haemoglobin of 7 or 9.

LiberalRestrictive

Eligibility Criteria

Age50 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may not qualify if:

  • Refusal of consent of patient (or consultee) Patient for palliative care.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Royal Hospital for Sick Children

Edinburgh, United Kingdom

Location

Related Publications (7)

  • Acheson AG, Brookes MJ, Spahn DR. Effects of allogeneic red blood cell transfusions on clinical outcomes in patients undergoing colorectal cancer surgery: a systematic review and meta-analysis. Ann Surg. 2012 Aug;256(2):235-44. doi: 10.1097/SLA.0b013e31825b35d5.

    PMID: 22791100BACKGROUND
  • Fowler AJ, Ahmad T, Phull MK, Allard S, Gillies MA, Pearse RM. Meta-analysis of the association between preoperative anaemia and mortality after surgery. Br J Surg. 2015 Oct;102(11):1314-24. doi: 10.1002/bjs.9861.

  • Davenport DL, Bowe EA, Henderson WG, Khuri SF, Mentzer RM Jr. National Surgical Quality Improvement Program (NSQIP) risk factors can be used to validate American Society of Anesthesiologists Physical Status Classification (ASA PS) levels. Ann Surg. 2006 May;243(5):636-41; discussion 641-4. doi: 10.1097/01.sla.0000216508.95556.cc.

  • Holst LB, Petersen MW, Haase N, Perner A, Wetterslev J. Restrictive versus liberal transfusion strategy for red blood cell transfusion: systematic review of randomised trials with meta-analysis and trial sequential analysis. BMJ. 2015 Mar 24;350:h1354. doi: 10.1136/bmj.h1354.

  • Carson JL, Stanworth SJ, Dennis JA, Fergusson DA, Pagano MB, Roubinian NH, Turgeon AF, Valentine S, Trivella M, Doree C, Hebert PC. Transfusion thresholds and other strategies for guiding red blood cell transfusion. Cochrane Database Syst Rev. 2025 Oct 20;10(10):CD002042. doi: 10.1002/14651858.CD002042.pub6.

  • Carson JL, Stanworth SJ, Dennis JA, Trivella M, Roubinian N, Fergusson DA, Triulzi D, Doree C, Hebert PC. Transfusion thresholds for guiding red blood cell transfusion. Cochrane Database Syst Rev. 2021 Dec 21;12(12):CD002042. doi: 10.1002/14651858.CD002042.pub5.

  • Gillies MA, Ghaffar S, Moppett IK, Docherty AB, Clarke S, Rea N, Stephen J, Keerie C, Ray DC, White TO, MacLullich AMJ, Mills NM, Rowley MR, Murthy K, Pearse RM, Stanworth SJ, Walsh TS. A restrictive versus liberal transfusion strategy to prevent myocardial injury in patients undergoing surgery for fractured neck of femur: a feasibility randomised trial (RESULT-NOF). Br J Anaesth. 2021 Jan;126(1):77-86. doi: 10.1016/j.bja.2020.06.048. Epub 2020 Jul 21.

MeSH Terms

Conditions

AnemiaCardiovascular DiseasesHip Fractures

Condition Hierarchy (Ancestors)

Hematologic DiseasesHemic and Lymphatic DiseasesFemoral FracturesFractures, BoneWounds and InjuriesHip InjuriesLeg Injuries

Study Officials

  • Dr.Mike Gillies

    Associate Medical Director

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 22, 2017

First Posted

January 23, 2018

Study Start

October 1, 2017

Primary Completion

March 1, 2019

Study Completion

June 1, 2019

Last Updated

March 11, 2020

Record last verified: 2018-03

Data Sharing

IPD Sharing
Will not share

Locations